Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Capital Expenditures (2016 - 2026)

Lifevantage filings provide 16 years of Capital Expenditures readings, the most recent being $1.1 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 120.33% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 45.6% increase, with the full-year FY2025 number at $1.4 million, down 38.93% from a year prior.
  • Capital Expenditures hit $1.1 million in Q4 2025 for Lifevantage, up from $439000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q1 2021 to a low of $199000.0 in Q2 2025.
  • Median Capital Expenditures over the past 5 years was $486000.0 (2021), compared with a mean of $597250.0.
  • Biggest five-year swings in Capital Expenditures: tumbled 78.89% in 2022 and later surged 171.23% in 2023.
  • Lifevantage's Capital Expenditures stood at $521000.0 in 2021, then surged by 60.65% to $837000.0 in 2022, then tumbled by 35.13% to $543000.0 in 2023, then decreased by 9.39% to $492000.0 in 2024, then soared by 120.33% to $1.1 million in 2025.
  • The last three reported values for Capital Expenditures were $1.1 million (Q4 2025), $439000.0 (Q3 2025), and $199000.0 (Q2 2025) per Business Quant data.